Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing

American Journal of Physiology - Cell Physiology

Volumn 304, Issue 9, 2013, Pages

  Turk, Harmony F ^a   Monk, Jennifer M ^a   Fan, Yang Yi ^a   Callaway, Evelyn S ^a   Weeks, Brad ^b   Chapkin, Robert S ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Colonic wounding; Epidermal growth factor receptor; Epithelial restitution; N 3 polyunsaturated fatty acids

Indexed keywords

DEXTRAN SULFATE; DOCOSAHEXAENOIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PLC GAMMA 1; PROTEIN; PROTEIN CDC42; RAC1 PROTEIN; RNA 18S; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; COLON; COLON MUCOSA; CONTROLLED STUDY; CYTOSKELETON; INTESTINAL WOUND HEALING; LIPID COMPOSITION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TRANSACTIVATION; WOUND HEALING;

COLONIC WOUNDING; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITHELIAL RESTITUTION; N-3 POLYUNSATURATED FATTY ACIDS;

ALPHA-LINOLENIC ACID; ANIMALS; ARACHIDONIC ACID; CDC42 GTP-BINDING PROTEIN; CELL MOVEMENT; CELLS, CULTURED; COLITIS; COLON; CORN OIL; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; NEUROPEPTIDES; OXYGEN CONSUMPTION; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RAC GTP-BINDING PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; WOUND HEALING;

MUS; ZEA MAYS;

EID: 84878641946     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00379.2012     Document Type: Article

References (55)

1. Ahdieh M, Vandenbos T, Youakim A. Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-γ. Am J Physiol Cell Physiol 281: C2029-C2038, 2001.
2. Al-Salihi MA, Ulmer SC, Doan T, Nelson CD, Crotty T, Prescott SM, Stafforini DM, Topham MK. Cyclooxygenase-2 transactivates the epi-dermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-α converting enzyme. Cell Signal 19: 1956-1963, 2007.
3. Bannenberg GL. Therapeutic applicability of anti-inflammatory and proresolving polyunsaturated fatty acid-derived lipid mediators. Sci World J 10: 676-712, 2010.
4. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334: 1557-1560, 1996.
5. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diepolder H, Marquardt A, Jagla W, Popp A, Leclair S, Herrmann K, Seiderer J, Ochsenkuhn T, Goke B, Auernhammer CJ, Dambacher J. IL-22 is increased in active Crohn's disease and promotes proinflamma-tory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 290: G827-G838, 2006.
6. Calder PC. Polyunsaturated fatty acids and inflammation. Biochem Soc Trans 33: 423-427, 2005.
7. Chapkin RS, McMurray DN, Davidson LA, Patil BS, Fan YY, Lupton JR. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br J Nutr 100: 1152-1157, 2008.
8. Chapkin RS, Wang N, Fan YY, Lupton JR, Prior IA. Docosahexaenoic acid alters the size and distribution of cell surface microdomains. Biochim Biophys Acta 1778: 466-471, 2008.
9. Conquer JA, Holub BJ. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J Nutr 126: 3032-3039, 1996.
10. Davidson LA, Lupton JR, Jiang YH, Chapkin RS. Carcinogen and dietary lipid regulate Ras expression and localization in rat colon without affecting farnesylation kinetics. Carcinogenesis 20: 785-791, 1999.
11. Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor-β. Gastroenter-ology 105: 1323-1332, 1993.
12. Dise RS, Frey MR, Whitehead RH, Polk DB. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 294: G276-G285, 2008.
13. Eden S, Rohatgi R, Podtelejnikov AV, Mann M, Kirschner MW. Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 418: 790-793, 2002.
14. Egan LJ, de Lecea A, Lehrman ED, Myhre GM, Eckmann L, Kagnoff MF. Nuclear factor-κB activation promotes restitution of wounded intes-tinal epithelial monolayers. Am J Physiol Cell Physiol 285: C1028-C1035, 2003.
15. El-Assal ON, Besner GE. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastro-enterology 129: 609-625, 2005.
16. El-Sibai M, Nalbant P, Pang H, Flinn RJ, Sarmiento C, Macaluso F, Cammer M, Condeelis JS, Hahn KM, Backer JM. Cdc42 is required for EGF-stimulated protrusion and motility in MTLn3 carcinoma cells. J Cell Sci 120: 3465-3474, 2007.
17. Goke M, Kanai M, Lynch-Devaney K, Podolsky DK. Rapid mitogen-activated protein kinase activation by transforming growth factor-α in wounded rat intestinal epithelial cells. Gastroenterology 114: 697-705, 1998.
18. Gravaghi C, La Perle KM, Ogrodwski P, Kang JX, Quimby F, Lipkin M, Lamprecht SA. Cox-2 expression, PGE2and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice. J Nutr Biochem 22: 360-365, 2011.
19. Hall A. Rho GTPases and the actin cytoskeleton. Science 279: 509-514, 1998.
20. Hawthorne AB, Daneshmend TK, Hawkey CJ, Belluzzi A, Everitt SJ, Holmes GK, Malkinson C, Shaheen MZ, Willars JE. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 33: 922-928, 1992.
21. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Burgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129: 550-564, 2005.
22. Holzer RG, Park EJ, Li N, Tran H, Chen M, Choi C, Solinas G, Karin M. Saturated fatty acids induce c-Src clustering within membrane sub-domains, leading to JNK activation. Cell 147: 173-184, 2011.
23. Hopkins AM, Pineda AA, Winfree LM, Brown GT, Laukoetter MG, Nusrat A. Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors. Am J Physiol Gastrointest Liver Physiol 292: G806-G817, 2007.
24. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106: 563-573, 2011.
25. Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A, Serhan CN, Kang JX. Transgenic mice rich in endogenous ω-3 fatty acids are protected from colitis. Proc Natl Acad Sci USA 103: 11276-11281, 2006.
26. Iizuka M, Konno S. Wound healing of intestinal epithelial cells. World J Gastroenterol 17: 2161-2171, 2011.
27. Jia Q, Lupton JR, Smith R, Weeks BR, Callaway E, Davidson LA, Kim W, Fan YY, Yang P, Newman RA, Kang JX, McMurray DN, Chapkin RS. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res 68: 3985-3991, 2008.
28. Kim JW, Sim SS, Kim UH, Nishibe S, Wahl MI, Carpenter G, Rhee SG. Tyrosine residues in bovine phospholipase C-γ phosphorylated by the epidermal growth factor receptor in vitro. J Biol Chem 265: 3940-3943, 1990.
29. Laroui H, Ingersoll SA, Liu HC, Baker MT, Ayyadurai S, Charania MA, Laroui F, Yan Y, Sitaraman SV, Merlin D. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with me-dium-chain-length fatty acids in the colon. PLos One 7: e32084, 2012.
30. Li S, Wang Q, Wang Y, Chen X, Wang Z. PLC-γ1and Rac1 coregulate EGF-induced cytoskeleton remodeling and cell migration. Mol Endocrinol 23: 901-913, 2009.
31. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflam-matory bowel disease-a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl 731: 225-232, 1989.
32. Ma DW, Finnell RH, Davidson LA, Callaway ES, Spiegelstein O, Piedrahita JA, Salbaum JM, Kappen C, Weeks BR, James J, Bozinov D, Lupton JR, Chapkin RS. Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res 65: 887-897, 2005.
33. McDaniel JC, Belury M, Ahijevych K, Blakely W. Omega-3 fatty acids effect on wound healing. Wound repair and regeneration. Wound Repair Regen 16: 337-345, 2008.
34. Monk JM, Jia Q, Callaway E, Weeks B, Alaniz RC, McMurray DN, Chapkin RS. Th17 cell accumulation is decreased during chronic exper-imental colitis by (n-3) PUFA in Fat-1 mice. J Nutr 142: 117-124, 2012.
35. Monk JM, Kim W, Callaway E, Turk HF, Foreman JE, Peters JM, He W, Weeks B, Alaniz RC, McMurray DN, Chapkin RS. Immunomodu-latory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis. Am J Physiol Gastrointest Liver Physiol 302: G153-G167, 2012.
36. Moyer RA, Wendt MK, Johanesen PA, Turner JR, Dwinell MB. Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia. Lab Invest 87: 807-817, 2007.
37. Oikonomou KA, Kapsoritakis AN, Kapsoritaki AI, Manolakis AC, Tsiopoulos FD, Germenis AE, Potamianos SP. Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage? Growth Factors 28: 461-466, 2010.
38. Oshima H, Popivanova BK, Oguma K, Kong D, Ishikawa TO, Oshima M. Activation of epidermal growth factor receptor signaling by the prostaglandin E2 receptor EP4 pathway during gastric tumorigenesis. Cancer Sci 102: 713-719, 2011.
39. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8: 289-293, 2002.
40. Peppelenbosch MP, Tertoolen LG, Hage WJ, de Laat SW. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell 74: 565-575, 1993.
41. Polk DB. Epidermal growth factor receptor-stimulated intestinal epithelial cell migration requires phospholipase C activity. Gastroenterology 114: 493-502, 1998.
42. Rogers KR, Kikawa KD, Mouradian M, Hernandez K, McKinnon KM, Ahwah SM, Pardini RS. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft asso-ciation. Carcinogenesis 31: 1523-1530, 2010.
43. Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, Takenawa T, Kirschner MW. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 97: 221-231, 1999.
44. Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M. Epithelial tight junctions in intestinal inflammation. Ann NY Acad Sci 1165: 294-300, 2009.
45. Seo J, Barhoumi R, Johnson AE, Lupton JR, Chapkin RS. Docosa-hexaenoic acid selectively inhibits plasma membrane targeting of lapidated proteins. FASEB J 20: 770-772, 2006.
46. Siddiqui RA, Harvey KA, Zaloga GP, Stillwell W. Modulation of lipid rafts by omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support. Nutr Clin Pract 22: 74-88, 2007.
47. Sinha A, Nightingale J, West KP, Berlanga-Acosta J, Playford RJ. Epidermal growth factor enemas with oral mesalamine for mild-to-mod-erate left-sided ulcerative colitis or proctitis. N Engl J Med 349: 350-357, 2003.
48. Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol 14: 348-353, 2008.
49. Trebble TM, Wootton SA, Miles EA, Mullee M, Arden NK, Ballinger AB, Stroud MA, Burdge GC, Calder PC. Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am J Clin Nutr 78: 376-382, 2003.
50. Turk HF, Barhoumi R, Chapkin RS. Alteration of EGFR spatiotempo-ral dynamics suppresses signal transduction. PLos One 7: e39682, 2012.
51. Turner D, Shah PS, Steinhart AH, Zlotkin S, Griffiths AM. Mainte-nance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses. Inflamm Bowel Dis 17: 336-345, 2011.
52. Wu CH, Wang CC, Kennedy J. Changes in herb and dietary supplement use in the US adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther 33: 1749-1758, 2011.
53. Xu KP, Yin J, Yu FS. SRC-family tyrosine kinases in wound-and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells. Invest Ophthalmol Vis Sci 47: 2832-2839, 2006.
54. Yan Y, Kolachala V, Dalmasso G, Nguyen H, Laroui H, Sitaraman SV, Merlin D. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLos One 4: e6073, 2009.
55. Yin J, Yu FS. ERK1/2 mediate wounding-and G-protein-coupled recep-tor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. Invest Ophthalmol Vis Sci 50: 132-139, 2009.